Stocks
GlaxoSmithKline (GSK) Cash US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Cash, £ | 5 871 540 750 | 7 877 000 000 | 6 606 013 600 | 3 714 000 000 | 3 400 013 000 | 4 540 284 000 | |||
| Changes by years, y/y, % | -33% | +34% | -16% | -44% | -8% | -17.1% | |||
GlaxoSmithKline. Cash, £
GlaxoSmithKline. Cash, changes, %
GlaxoSmithKline (GSK) Cash US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Cash, £ | 4 959 297 000 | 4 450 703 000 | 3 400 013 000 | 3 400 013 000 | 4 540 284 000 | 4 540 284 000 | ||
| Changes by years, y/y, % | +32% | +39% | -8% | -8% | -22% | |||
| Changes by quarters, q/q, % | -14% | -10% | -24% | 0% | +34% | |||
